Harvard Bioscience
(NASDAQ) HBIO
Harvard Bioscience Financials at a Glance
Market Cap
$23.25M
Revenue (TTM)
$86.55M
Net Income (TTM)
$56.70M
EPS (TTM)
$-12.85
P/E Ratio
-0.40
Dividend
$0.00
Beta (Volatility)
1.37 (Average)
Dividend
$0.00
Beta (Volatility)
1.37 (Average)
Price
$5.21
Volume
31,042.522
Open
$5.00
Price
$5.21
Volume
31,042.522
Open
$5.00
Previous Close
$5.20
Daily Range
$5.00 - $5.27
52-Week Range
$2.81 - $9.46
Dividend
$0.00
Beta (Volatility)
1.37 (Average)
Price
$5.21
Volume
31,042.522
Open
$5.00
Previous Close
$5.20
Daily Range
$5.00 - $5.27
52-Week Range
$2.81 - $9.46
HBIO News
I’m Selling Harvard Biosciences
Tomorrow's Monster Stock?
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Harvard Bioscience
Industry
Life Sciences Tools and Services
Sector
Health CareEmployees
339
CEO
John D. Duke, MBA
Website
www.harvardbioscience.comHeadquarters
Holliston, MA 01746, US
HBIO Financials
Key Financial Metrics (TTM)
Gross Margin
53%
Operating Margin
-56%
Net Income Margin
-66%
Return on Equity
-147%
Return on Capital
-83%
Return on Assets
-71%
Earnings Yield
-2.50%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$23.25M
Shares Outstanding
4.47M
Volume
31.04K
Short Interest
0.00%
Avg. Volume
48.04K
Financials (TTM)
Gross Profit
$45.88M
Operating Income
$629.00K
EBITDA
$5.32M
Operating Cash Flow
$6.73M
Capital Expenditure
$1.11M
Free Cash Flow
$5.62M
Cash & ST Invst.
$8.61M
Total Debt
$44.28M
Harvard Bioscience Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$23.73M
-3.3%
Gross Profit
$11.31M
-19.3%
Gross Margin
47.64%
N/A
Market Cap
$23.25M
N/A
Market Cap/Employee
$70.47K
N/A
Employees
330
N/A
Net Income
$2.85M
-15916.7%
EBITDA
$52.34M
+1534.2%
Quarterly Fundamentals
Net Cash
$35.66M
+11.7%
Accounts Receivable
$16.04M
+7.9%
Inventory
$20.80M
-10.5%
Long Term Debt
$42.75M
+570.0%
Short Term Debt
$1.52M
-96.0%
Return on Assets
-70.81%
N/A
Return on Invested Capital
-83.23%
N/A
Free Cash Flow
$545.00K
-143.3%
Operating Cash Flow
$96.00K
-105.6%